drugset / Trial / NCT00480753

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

NCT00480753

Phase 2 Completed 15 enrolled MediQuest Therapeutics
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this clinical study is to determine the response to two different dosage strengths of a topical nitroglycerin gel in patients with Raynaud's Phenomenon. Patient fingers will be monitored for changes in blood flow and skin temperature. Symptoms of pain, tingling and numbness will also be monitored.

Timeline

Start
2007-05
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown Topical

Indications